Category Archives: Prescription Drugs

CMS Rule Undermines Real Cost Savings For Consumers & Could Cripple Fledgling U.S. Biosimilar Market

The Obama administration is proposing a Medicare payment rule that would have the effect of clamping price controls on biosimilar drugs, extending destructive pricing policies to a potentially vibrant 21st century life sciences industry. The Centers for Medicare and Medicaid Services (CMS) has proposed a rule that would guide how Medicare pays for a new […]

Read More

First Biosimilar Medicine Launches; Price Disappoints Those Hoping For Deeper Discount

Pharmaceutical prices are dominating public concerns about health care, according to a recent poll by the Kaiser Family Foundation that shows three-quarters of Americans support limiting how much drug companies can charge for high-cost drugs.  So it’s especially disappointing to see that the first imitators of a new generation of biologic cancer drugs approved for […]

Read More